ArticleBulletin of experimental biology and medicine2026
CK19 and PDX1 as Markers of Differentiation and Maturation of Pancreatic Islet Endocrine Cells.
Article in Bulletin of experimental biology and medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We studied patterns of staining for early cell markers in the forming pancreatic islets during months 5 and 6 of human prenatal development. The study was performed on 10 autopsy specimens of the fetal pancreas (gestational age 16-23 weeks) using multiple immunohistochemical staining with antibodies to PDX1 and CK19. Two main types of cells have been identified: cells with the intense staining for PDX1 and weak or no staining for CK19 that were located in the central area of the mantle islets or at one the poles of bipolar islets and may be referred to a population of β cells and cells with staining for CK19 and weak or no staining for PDX1 that were located at the periphery of the mantle islets or at the other pole of bipolar islets and may be referred to a population of α cells. The islet cells had additional phenotypes based on the staining for CK19 and PDX1, which requires further studies to determine the fate of these cells.
Indexed as
Identifiers
42030021What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.